These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27978645)

  • 1. Spirodalesol, an NLRP3 Inflammasome Activation Inhibitor.
    Zhang AH; Liu W; Jiang N; Xu Q; Tan RX
    Org Lett; 2016 Dec; 18(24):6496-6499. PubMed ID: 27978645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spirodalesol analog 8A inhibits NLRP3 inflammasome activation and attenuates inflammatory disease by directly targeting adaptor protein ASC.
    Liu W; Yang J; Fang S; Jiao C; Gao J; Zhang A; Wu T; Tan R; Xu Q; Guo W
    J Biol Chem; 2022 Dec; 298(12):102696. PubMed ID: 36379253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors.
    Cocco M; Miglio G; Giorgis M; Garella D; Marini E; Costale A; Regazzoni L; Vistoli G; Orioli M; Massulaha-Ahmed R; Détraz-Durieux I; Groslambert M; Py BF; Bertinaria M
    ChemMedChem; 2016 Aug; 11(16):1790-803. PubMed ID: 26990578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 1,5-Anhydro-d-fructose derivatives and evaluation of their inflammasome inhibitors.
    Goto K; Ideo H; Tsuchida A; Hirose Y; Maruyama I; Noma S; Shirai T; Amano J; Mizuno M; Matsuda A
    Bioorg Med Chem; 2018 Jul; 26(13):3763-3772. PubMed ID: 30017113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
    Zhang X; Xu A; Lv J; Zhang Q; Ran Y; Wei C; Wu J
    Eur J Med Chem; 2020 Jan; 185():111822. PubMed ID: 31699536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NLRP3 inflammasome attenuates spinal cord injury-induced lung injury in mice.
    Jiang W; Li M; He F; Zhu L
    J Cell Physiol; 2019 May; 234(5):6012-6022. PubMed ID: 30589073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new pharmacological effect of levornidazole: Inhibition of NLRP3 inflammasome activation.
    Wang X; Wang S; Hu C; Chen W; Shen Y; Wu X; Sun Y; Xu Q
    Biochem Pharmacol; 2015 Sep; 97(2):178-88. PubMed ID: 26212544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
    Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
    Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
    Shim DW; Lee KH
    Front Immunol; 2018; 9():1054. PubMed ID: 29868015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-11-5-27, a daidzein derivative, inhibits NLRP3 inflammasome activity via promoting autophagy.
    Zhou W; Liu X; Cheng K; Zhang X; Lu J; Hu R
    Exp Cell Res; 2017 Nov; 360(2):320-327. PubMed ID: 28942022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Antimalarial Chloroquine Suppresses LPS-Induced NLRP3 Inflammasome Activation and Confers Protection against Murine Endotoxic Shock.
    Chen X; Wang N; Zhu Y; Lu Y; Liu X; Zheng J
    Mediators Inflamm; 2017; 2017():6543237. PubMed ID: 28321151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of dronedarone and its analogues as NLRP3 inflammasome inhibitors with potent anti-inflammation activity.
    Chen H; Chen X; Sun P; Wu D; Yue H; Pan J; Li X; Zhang C; Wu X; Hua L; Hu W; Yang Z
    Bioorg Med Chem Lett; 2021 Aug; 46():128160. PubMed ID: 34062252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement.
    Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q
    Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity.
    Bertinaria M; Gastaldi S; Marini E; Giorgis M
    Arch Biochem Biophys; 2019 Jul; 670():116-139. PubMed ID: 30448387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages.
    Yeon SH; Yang G; Lee HE; Lee JY
    J Leukoc Biol; 2017 Jan; 101(1):205-215. PubMed ID: 27256568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NLRP3 Inflammasome as a Pharmacological Target.
    Marchetti C
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
    Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
    Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y
    Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toonaolides A-X, limonoids from Toona ciliata: Isolation, structural elucidation, and bioactivity against NLRP3 inflammasome.
    Shi QQ; Zhang XJ; Zhang Y; Wang Q; Amin M; Li Q; Wu XW; Li XL; Zhang RH; Dai XC; Xiao WL
    Bioorg Chem; 2020 Dec; 105():104363. PubMed ID: 33075665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation.
    Ohto U; Kamitsukasa Y; Ishida H; Zhang Z; Murakami K; Hirama C; Maekawa S; Shimizu T
    Proc Natl Acad Sci U S A; 2022 Mar; 119(11):e2121353119. PubMed ID: 35254907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.